Drug test

Cordant Offers Telemedicine Solution for Drug Testing to Help Provide Critical Care to Addiction and Mental Health Patients During COVID-19 Pandemic

Retrieved on: 
Wednesday, April 8, 2020
Opioids, Articles, RTT, Morphinans, Drug rehabilitation, Ethers, Phenols, Buprenorphine, Drug test, Telehealth, Mental health, Pharmacy

DENVER, April 8, 2020 /PRNewswire/ --Cordant Health Solutions (Cordant) offers a video-observed oral fluid drug testing solution ideal for addiction treatment organizations and government agencies to help continue to provide critical care to individuals recovering from substance use disorder.

Key Points: 
  • DENVER, April 8, 2020 /PRNewswire/ --Cordant Health Solutions (Cordant) offers a video-observed oral fluid drug testing solution ideal for addiction treatment organizations and government agencies to help continue to provide critical care to individuals recovering from substance use disorder.
  • While many may already offer telemedicine, services like drug testing to monitor adherence are a challenge in this environment.
  • Cordant also currently has one of the largest mental health testing menus, with the ability to test for 55 mental health medications using saliva.
  • To further enhance patient safety, Cordant offers a pharmacy solution that can help ensure patients have convenient and reliable access to buprenorphine.

The Background Buzz, the leading e-magazine for HR and background screening professionals adds Social Media and Drug Screening 'Thought Leadership' content columns

Retrieved on: 
Wednesday, February 26, 2020
Recruitment, Medical tests, Medicine, Criminal records, Background check, Law enforcement, Security, Health, Human activities, Screening, Drug test

ALPHARETTA, Ga, Feb. 26, 2020 /PRNewswire-PRWeb/ --The Background Buzz, the industry leading e-magazine for HR and background screening professionals added 'Social Media' and 'Drug Screening' Thought Leadership content columns to address 'hot issues' in background screening in the January edition.

Key Points: 
  • ALPHARETTA, Ga, Feb. 26, 2020 /PRNewswire-PRWeb/ --The Background Buzz, the industry leading e-magazine for HR and background screening professionals added 'Social Media' and 'Drug Screening' Thought Leadership content columns to address 'hot issues' in background screening in the January edition.
  • The Social Intelligence, column will focus on the emerging practice of employers conducting social media checks during the hiring process.
  • The second column, Inside Drug Screening, is focused on emerging issues in drug screening.
  • Nixon added, "We have been working with the background screening industry since 2002 and have never seen a time when drug screening was more important than now.

Cannabix Technologies Appoints VP of Technology Development

Retrieved on: 
Tuesday, February 11, 2020
Nanotechnology, Articles, Materials science, Technology, Microfluidics, Biotechnology, Fluid dynamics, Lab-on-a-chip, Breathalyzer, Workplace, Drug test, CHIP

VANCOUVER, British Columbia, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the Company or Cannabix) developer of marijuana breathalyzer devices for law enforcement and the workplace is pleased to report that Dr. Moe Paknahad has joined the Company as VP of Technology Development.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the Company or Cannabix) developer of marijuana breathalyzer devices for law enforcement and the workplace is pleased to report that Dr. Moe Paknahad has joined the Company as VP of Technology Development.
  • He is a specialist in the areas of microfluidics, machine olfaction, sensors, organ-on-chip and lab-on-chip technologies.
  • More recently he served as a product development specialist at CellScale Biomaterials and VitroFlo based in Ontario developing organ-on-chip in-vitro devices for drug screening purposes.
  • Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace.

Workplace Drug Testing Expert Nina French Joins Hound Labs as Senior Vice President of Employer Solutions

Retrieved on: 
Tuesday, February 11, 2020
Medical tests, Doping in sport, Drug control law, Drug test, Tests, Workplace, Human activities, Humans

OAKLAND, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Hound Labs Inc., creator of the worlds first dual marijuana and alcohol breathalyzer, announced today that Ms. Nina French, a nationally-recognized expert in workplace drug testing, has joined the Hound Labs team as its Senior Vice President of Employer Solutions.

Key Points: 
  • OAKLAND, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Hound Labs Inc., creator of the worlds first dual marijuana and alcohol breathalyzer, announced today that Ms. Nina French, a nationally-recognized expert in workplace drug testing, has joined the Hound Labs team as its Senior Vice President of Employer Solutions.
  • French will lead the team developing drug testing solutions for employers, including the Hound Labs charter customer program launching in late Q1 2020.
  • Her expertise in the employer screening industry and her insight into the future of workplace drug testing will help Hound Labs tailor solutions for employers who want to balance safety and fairness in the workplace.
  • Formerly a co-founder and managing partner for Current Consulting Group, LLC (CCG), French is an expert in substance abuse testing.

2020 Drugs of Abuse Testing Market for 12 Assays - Supplier Shares & Strategies, Volume & Sales Segment Forecasts & Profiles of Leading Competitors - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 6, 2020
Health, General Health, Natural sciences, Physical sciences, Chemistry, Assay, Biochemistry, Titration, Market segmentation, Forecasting, Drug test

This new 318-page report from the author contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Key Points: 
  • This new 318-page report from the author contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
  • The report provides test volume and sales forecasts by country and market segment for the following assays:
    During the next decade, the abused drug testing market will undergo significant transformation.
  • Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.
  • The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.

Drug of Abuse Testing Market Insights 2013-2020 and Forecast to 2025

Retrieved on: 
Thursday, January 23, 2020
Alcohol law, Breathalyzer, Driving under the influence, Spectroscopy, Substance abuse, Medical tests, Psychoactive drugs, Drug test, Human activities

On the basis of product type, the drugs of abuse testing market have been segmented into consumables and equipment market.

Key Points: 
  • On the basis of product type, the drugs of abuse testing market have been segmented into consumables and equipment market.
  • The equipment used in drug of abuse testing market include immunoassay analyzers, chromatography instruments and breath analyzers.
  • The global drug of abuse lab-based testing market is predicted to reach close to US$ 1 Billion by 2025.
  • The report titled Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profiles - Global Forecast to 2025 provides a comprehensive assessment of the fast-evolving high growth drug of abuse testing market.

First-of-Its-Kind "U.S. Drug Testing 2020: Trends and Predictions" Report from Confirm BioSciences Highlights New Challenges for Employers, Need for Flexible Testing

Retrieved on: 
Wednesday, January 22, 2020
Medical tests, Doping in sport, Drug control law, Drug test, Tests, Workplace, Medicine, Clinical medicine, Human activities, Cannabis

"This report details the changes, highlights the challenges and provides an overview of practical solutions that can help people successfully navigate the rapidly changing environment."

Key Points: 
  • "This report details the changes, highlights the challenges and provides an overview of practical solutions that can help people successfully navigate the rapidly changing environment."
  • The Confirm BioSciences study also highlights employer and employee confusion on how to proceed with testing in states where marijuana use is legal.
  • "There are three kinds of drug testing methods that are widely admissible at the state level: urine, oral fluid and hair testing.
  • To view or download the full U.S. Drug Testing 2020: Trends and Predictions report, please visit https://www.confirmbiosciences.com/knowledge/blog/ .

PreemploymentDirectory.com, the leading background screening information portal for the HR community, publishes new guide on How to Select a Drug Screening Provider

Retrieved on: 
Wednesday, January 8, 2020
Recruitment, Human activities, Screening, Background check, Drug test, Human behavior, Humans

ALPHARETTA, Ga., Jan. 8, 2020 /PRNewswire-PRWeb/ -- PreemploymentDirectory.com, the background screening news and information portal for Human Resources professionals and Hiring Managers, has published an informative new guide on 'How to Select a Drug & Alcohol Screening Provider' to help employers select the right drug screening provider to meet their hiring needs at a time when drug use is on the increase.

Key Points: 
  • ALPHARETTA, Ga., Jan. 8, 2020 /PRNewswire-PRWeb/ -- PreemploymentDirectory.com, the background screening news and information portal for Human Resources professionals and Hiring Managers, has published an informative new guide on 'How to Select a Drug & Alcohol Screening Provider' to help employers select the right drug screening provider to meet their hiring needs at a time when drug use is on the increase.
  • The 'How to Select a Drug & Alcohol Screening Provider' guide was written specifically to help employers to select a drug testing provider who can meet their company's needs and to guide them in defining a successful program.
  • Nixon added, "In these litigious times with marijuana lawsuits increasingly challenging employers' drug screening practices it is more important than ever for employers to understand industry best practices and to carefully select their drug screening provider.
  • The web site also includes a Background Screening Publications Center which houses many of our publications: The Background Buzz, The Global Background Screener, In Search of Excellence in Background Screening: Best Practice Insights from Accredited Background Screening Firms, Women Leaders Thriving in the Background Screening Industry to name a few.

Real-Time Evaluation of Urine Drug Test Results from Millennium Health Uncovers Significant Increase in Positives for Methamphetamine and Fentanyl According to JAMA Network Open Study

Retrieved on: 
Monday, January 6, 2020
Drugs, Psychoactive drugs, Euphoriants, Organic compounds, RTT, Fentanyl, Drug test, Heroin, Intervention, Cocaine

SAN DIEGO, Jan. 6, 2020 /PRNewswire/ -- A study by Millennium Health published in JAMA Network Open reports that since 2016, rates of positive definitive urine drug test (UDT) results have increased significantly by 42.44% for methamphetamine and 75.46% for fentanyl.

Key Points: 
  • SAN DIEGO, Jan. 6, 2020 /PRNewswire/ -- A study by Millennium Health published in JAMA Network Open reports that since 2016, rates of positive definitive urine drug test (UDT) results have increased significantly by 42.44% for methamphetamine and 75.46% for fentanyl.
  • This is in sharp contrast to cocaine and heroin, where positivity peaked in 2016 and has since declined by 3.70% and 21.65%, respectively.
  • The results also revealed that among UDT results positive for fentanyl, methamphetamine positivity continued to increase after 2016 by 153.51%.
  • Earlier identification of these trends also supports the development of targeted interventions to curb the impact on public health.

Global $5 Billion Drug Abuse Testing Market Forecast to 2025 by Products (Consumable, Equipment - Immunoassay Analyzers, Breath Analyzers, others), Tests, Regions, Companies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 18, 2019
Medical devices, Health, Alcohol law, Breathalyzer, Driving under the influence, Spectroscopy, Medical tests, Drug culture, Medicine, Clinical medicine, Psychoactive drugs, Drug test

The "Drug Abuse Testing Market Global Forecast by Products (Consumable, Equipment - Immunoassay Analyzers, Breath Analyzers, others), Tests, Regions, Companies" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Abuse Testing Market Global Forecast by Products (Consumable, Equipment - Immunoassay Analyzers, Breath Analyzers, others), Tests, Regions, Companies" report has been added to ResearchAndMarkets.com's offering.
  • The Global Drug Abuse Testing Market will surpass US$ 5 Billion by the year-end of 2025.
  • Drug abuse testing initially includes a basic screening test to find out the quantity of drugs present in the body.
  • Besides, companies are launching innovative equipment and reagent for early and accurate detection that will further propel the global drug of abuse testing market in the forecast year.